We are live on
!
Find out more
BWLSA
Blue Water Life Science Advisors Portfolio holdings
AUM
$159M
1-Year Est. Return
139.66%
This Fund
S&P 500
This Quarter
Est. Return
-22.98%
1 Year Est. Return
+139.66%
3 Year Est. Return
+503.09%
5 Year Est. Return
+228.74%
10 Year Est. Return
–
AUM
$106M
AUM Growth
-$42.2M
(-29%)
Cap. Flow
-$5.48M
Cap. Flow
% of AUM
-5.17%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
1
Reduced
2
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NSTG
NanoString Technologies, Inc.
NSTG
|
+$3.12M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adaptive Biotechnologies
ADPT
|
+$4.32M |
| 2 |
Natera
NTRA
|
+$4.28M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
Similar funds
SFC
ACP
CW
SG
LA
CMMS
JWM
AC
Blue Water Life Science Advisors's Q3 2023 Portfolio in Review
As of Q3 2023, Blue Water Life Science Advisors held 7 positions worth $106M, down 29% from $148M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Blue Water Life Science Advisors withdrew a net $5.48M in Q3 2023, reducing 2 holdings. Its largest reduction was Adaptive Biotechnologies, cutting an estimated $4.32M.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.
Against the trend, Blue Water Life Science Advisors added an estimated $3.12M to NanoString Technologies, Inc..
- Blue Water Life Science Advisors added most to NanoString Technologies, Inc. in Q3 2023, an estimated $3.12M increase.
- Blue Water Life Science Advisors's biggest Q3 2023 reduction was Adaptive Biotechnologies, cutting an estimated $4.32M.
- Blue Water Life Science Advisors's ten largest holdings make up 100% of its $106M portfolio in Q3 2023.
- Blue Water Life Science Advisors opened 0 new positions and closed 0 in Q3 2023.
- Blue Water Life Science Advisors's portfolio value fell 29% quarter-over-quarter to $106M.
Based on Blue Water Life Science Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.